Precision AQ’s Post

Enhancing Digital Health Measurement: Digital Medicine Society (DiMe), The Michael J. Fox Foundation for Parkinson's Research (MJFF), and Critical Path Institute (C-Path) Expand Library for Parkinson’s Research Learn more & get our take 👇 https://lnkd.in/gwsCQ2wr “Broad adoption of high-quality, fit-for-purpose digital measurement products promises to speed the inclusive development of new PD therapies, improve access to PD trials and specialist care by supporting decentralized and virtual research and care models, support earlier diagnoses, and improve outcomes through the identification of digital phenotypes.” — Jennifer Goldsack, CEO at DiMe “The release of this centralized, open-source resource is a critical step forward for clinicians, developers, or researchers looking for evidence-based tools. The data sets give users the information needed to expedite timelines, facilitate assessment of the landscape for sensor-based digital health technologies, and allow benchmarking of digital innovation in PD to other related therapeutic areas, which was previously inaccessible.” — Yuge Xiao, Clinical Research Lead at MJFF “Sensor-based digital health technologies can bridge this gap by enabling remote and frequent measurement of PD symptoms, supporting early intervention, innovative treatments, and improved outcomes for patients. Collaborative approaches to collecting and cataloging this information, and making it broadly accessible, will help advance the field in unprecedented ways.” — Diane Stephenson, Executive Director at CPP #DiMe #digitalhealth #SoHCNews

📆 Don't miss our upcoming live Digital Health Monthly scientific webinar - Accelerating DHT Research and Drug Development with Open-source Big Data from Population Studies! Register today 👉 https://hubs.la/Q02Zl6HR0 📈 Dr. Dana Wolff-Hughes, Program Director at NIH, will provide an overview of the National Health, Nutrition, and Exercise Survey (NHANES) and share details on the data collection plans for the upcoming survey, including the addition of vital sign data using wearable DHTs. 📉 Dr. Andy Liu, Biostatistician at ActiGraph, will discuss a recent project utilizing actigraphy data from NHANES to develop best practices to derive reliable clinical outcome scores from continuous DHT data. What You'll Learn: ✅ How large-scale population studies provide a rich and diverse wearable-derived data set that otherwise clinical researchers would not have the means to collect ✅ How this data can be leveraged to expand the analyses researchers can perform to address key health-related questions #DigitalHealthMonthly #DHT #NHANES #BigData #ClinicalResearch #DrugDevelopment

The heartbreaking news about Relyvrio is another reminder of the challenges we face in treating ALS. Better outcome measures could improve the confidence in assessing clinical efficacy of potential thareputics. Join us to discussed the latest in patient-centric outcomes powered by wearable DHTs.

When I say our #data and #insights is positively #disruptive in #specialtycare—here is another example of Amplity Health insights at work 🙌🏾 #ISPOREurope in November is lined up to be a treat, no tricks 😉! Reach out if you will be in attendance and meet our team! Learn how Amplity Insights disrupts data norms by uncovering the “why” behind patient and provider treatment decisions. https://lnkd.in/gkEPKb2R #actionableinsights #realworldapplication #qualitativeinsights

#mdpijpm Congratulations 🎉 The eighth paper published in the Special Issue "𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐨𝐟 𝐁𝐢𝐨𝐬𝐩𝐞𝐜𝐭𝐫𝐨𝐬𝐜𝐨𝐩𝐲 𝐚𝐧𝐝 𝐈𝐦𝐚𝐠𝐢𝐧𝐠" 🖋 Edited by Prof. Dr. Francis Martin 🔥 Published 8 papers | Viewed by 10383 📑#Biospectroscopy involves an emerging interdisciplinary approach with the potential to revolutionize healthcare #diagnosis and #screening. 👏 Welcome to reading and submit your latest research to update progress on this topic jointly! 🍻 https://lnkd.in/dJ5X6pQP

The Freedland Research Group, affiliated to the Durham VA Healthcare System will be at the upcoming #ASCO2024 conference. If you'd like to connect about conducting research within the VA, please let me know. Our team can help with rapid nationwide patient recruitment for HEOR/RWE/Validation studies, procure biospecimen and more! #Liquidbiopsy #Clinicalresearch #CancerLinQ #OncoDaily

Molecular You is thrilled to partner with HealthQuest Esoterics, a leader in laboratory testing, to expand access to molecular medicine across the U.S.!🎉 Together, we’re on a mission to transform preventive care, address health issues at the root cause, and improve health outcomes for healthcare providers and their patients. 🧬💡 "Partnering with HealthQuest Esoterics is a key step in our mission to expand access to molecular medicine," said Jim Kean, CEO of Molecular You. "We're excited to see our molecular testing and analytics solutions implemented across the U.S., helping practitioners to better understand their patients' health through detailed biomarker insights, and take action even before symptoms appear." Read about the partnership on this link: https://bit.ly/3O4yY8Y #MolecularYou #HealthQuestEsoterics #PreventiveCare #PredictiveMedicine #HealthcareInnovation #BiomarkerInsights

📢 New Article Published Online 📢 #EMD   📰 #Perspective: Opportunities of digital health technologies for rheumatology: from clinics to quality and research 🖋 Authors: Michael Schirmer, Lukas Kampik, Johannes D. Pallua 💡 Keywords: #DigitalHealth, #Rheumatology, #Quality, #ObservationalTrial   ⭐ This narrative review aims to summarize the concept of consecutive cohorts with local research experiences in consecutive rheumatic outpatients, together with a proposal to develop digital health technologies in a clinical setting.   🔎 Read the full article at https://lnkd.in/gDmKyxgR 🔎 PDF: https://lnkd.in/gA535gCM   ✅ This article belongs to the special issue "Digital health technologies in rheumatology: emerging evidence and innovation" edited by Prof. Rebecca Grainger. (https://lnkd.in/guepaKWX)

🗞 We are delighted that an article authored by Maddy Dawson and Nancy Cross, current and former Consultants at Lightning Health has been published in the latest issue of ISPOR's Value and Outcomes Spotlight. 🗞 The Value of Technology to Reduce Barriers to Clinical Trial Diversity and Facilitate the Development of Patient-Centric Medicine explores the underrepresentation of many patient subpopulations in clinical trials. 🔎 Through stakeholder research, the authors identified that a lack of diversity in clinical trials has implications on the generalizability of results to the real-world population, resulting in treatment gaps, unsafe dosing and reduced access to innovative medicines in the underrepresented groups. 🔎 The research found that digital technologies can increase representation when implemented appropriately in clinical trials Maddy Dawson said, "It’s amazing to see that this topic has been highlighted as an area of interest. Hopefully this will help to raise awareness of the lack of diversity in clinical trials and the impact this has on patients in the real-world setting." Read the full article on page 30 https://lnkd.in/e9E4buQe #clinicaltrials #clinicaltrialdiversity #patientpopulations #payerinsights #kolinsights

We are proud to advance rare disease research and patient outcomes. In collaboration with The National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), and the GW Computational Biology Institute, CVP recently published its work analyzing national insurance claims data to better understand diagnosis, treatment, and costs associated with 14 rare diseases. Key findings: ▶️ Significant variability in prevalence and costs across US regions and between urban/rural areas. ▶️ Pharmacy costs increased with new treatments, while non-pharmacy costs (inpatient, outpatient, and/or physician costs) decreased. ▶️ Challenges in prevalence estimation are due to limited data and coding issues. See the complete publication @ https://lnkd.in/gHCZ7Aqt #BMJPublicHealth #Publication #PublicHealth #NIH #NCATS #CVPHRT #RareDisease #HealthcareInnovation #DataAnalytics #PatientCare Reva Stidd, MS, MBA, PMP, Manpreet Khural